Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivanib and Irinotecan in Metastatic Colorectal Cancer
NCT01367275Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2011
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
A Phase 2 trial of brivanib in colorectal adenocarcinoma, sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2011; status: terminated.
02
Drugs
brivanib
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT01367275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367275.